Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
TMCI
$4.79
+6.21%
TMCI · Treace Medical Concepts, Inc.
$4.79
+0.28 (+6.21%)
At close · Aug 14
Market Cap
$311.52M
Shares
65.03M
All earnings calls
Earnings call · FY2026 Q1
Treace Medical Concepts, Inc. Q1 FY2026 Earnings Call
Treace Medical Concepts, Inc. Q1 FY2026 Earnings Call
Forward guidance
3 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$47.20M
-10.2% YoY
Diluted EPS
-$0.28
Gross margin
79.3%
-0.4 pp YoY
Net income
-$17.96M
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed May 8, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Revenue
full-year 2026
|
$202M – $212M | — | |
|
Adjusted EBITDA
full year 2026
|
$-6M – $-4M | Non-GAAP | |
|
Cash usage
full-year 2026
|
up to 50% | — |
SEC filing · Item 2.02
8-K earnings release
Filed May 8, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed May 8, 2026 · complete as-filed document